THE REPORT URGES A SHIFT TOWARD MORE INCLUSIVE TRIAL STRATEGIES, INCLUDING TAILORED RECRUITMENT, COMMUNITY-BASED APPROACHES AND EDUCATION PLANS FOR BOTH PARTICIPANTS AND INVESTIGATORS. recruitment, community-based approaches and education plans for both participants and investigators.
H E A L T H I N S I G H T S
sight of any specific effects on women in a mass of aggregated data.
4. Design clinical trials with women in mind
The report urges a shift toward more inclusive trial strategies, including tailored
THE REPORT URGES A SHIFT TOWARD MORE INCLUSIVE TRIAL STRATEGIES, INCLUDING TAILORED RECRUITMENT, COMMUNITY-BASED APPROACHES AND EDUCATION PLANS FOR BOTH PARTICIPANTS AND INVESTIGATORS. recruitment, community-based approaches and education plans for both participants and investigators.
5. Share clearer information on sexspecific differences
The report calls for clinical guidelines, drug labelling and patient information to be updated to reflect sex-specific differences in safety, efficacy and dosing. These updates should be based on sexdisaggregated trial data and form a standard part of regulatory approval.
Paula Bellostas Muguerza, Global Lead of Kearney’ s Healthcare and Life Sciences practice, said:“ For too many women, healthcare still means misdiagnoses, delayed treatment and hitting dead ends. I’ ve been there, waiting months for answers, being
18 www. intelligenthealth. tech